Alnylam Pharmaceuticals
ALNY
ALNY
198 hedge funds and large institutions have $4.22B invested in Alnylam Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 36 closing their positions.
Holders
198
Holders Change
-12
Holders Change %
-5.71%
% of All Funds
4.94%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
29
Increased
63
Reduced
72
Closed
36
Calls
$45.9M
Puts
$43.4M
Net Calls
+$2.52M
Net Calls Change
+$5.39M
Top Buyers
| 1 |
1
BlackRock
New York
|
$243M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$56.6M |
| 3 |
RFS
3
Rockefeller Financial Services
New York
|
$25.9M |
| 4 |
4
Goldman Sachs
New York
|
$70.9M |
| 5 |
RI
5
RTW Investments
New York
|
$56M |
Top Sellers
| 1 |
1
Legal & General Group
London,
United Kingdom
|
$1.27M |
| 2 |
2
Millennium Management
New York
|
$596K |
| 3 |
AG
3
Artal Group
Luxembourg
|
$15.4M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$111M |
| 5 |
TCM
5
TimesSquare Capital Management
New York
|
$2.05M |
